EviCure

EviCure
Developing exosome-based cancer therapeutics using AI and novel human cancer models.
Rate
About
EviCure Life Sciences is a startup focused on developing exosome-based therapeutics for cancer treatment. They leverage artificial intelligence, novel human cancer modeling, and controlled manufacturing capabilities to create these innovative treatments, with an initial focus on lung cancer.
Technology stack
detected 2026-07-01Emailunknown
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does EviCure do?
EviCure Life Sciences is a startup focused on developing exosome-based therapeutics for cancer treatment. They leverage artificial intelligence, novel human cancer modeling, and controlled manufacturing capabilities to create these innovative treatments, with an initial focus on lung cancer.
Where is EviCure headquartered?
EviCure is headquartered in San Diego, United States.
When was EviCure founded?
EviCure was founded in 2023.
What industry does EviCure operate in?
EviCure operates in Life Sciences, Oncology, Lung, Biomarkers, Therapeutics, Biotech.